Patents by Inventor Kiyotaka Suenaga

Kiyotaka Suenaga has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prophylactic vaccine against egg drop syndrome (EDS)
    Patent number: 10253072
    Abstract: The present invention is intended to provide an egg drop syndrome (EDS) vaccine that is capable of effectively preventing EDS and can be stably supplied. The EDS vaccine provided to this end contains as an active ingredient fused protein in which a polypeptide having a coiled-coil forming unit is bound to the knob region in the fiber protein of EDS virus (EDSV).
    Type: Grant
    Filed: March 16, 2015
    Date of Patent: April 9, 2019
    Assignee: KM Biologics Co., Ltd.
    Inventors: Kenichi Yamazaki, Kiyohiko Andoh, Ryuichi Sakamoto, Kiyotaka Suenaga, Takeshi Arakawa, Hirotaka Uefuji, Tetsuya Harakuni, Takeshi Miyata
  • PROPHYLACTIC VACCINE AGAINST EGG DROP SYNDROME (EDS)
    Publication number: 20170044217
    Abstract: The present invention is intended to provide an egg drop syndrome (EDS) vaccine that is capable of effectively preventing EDS and can be stably supplied. The EDS vaccine provided to this end contains as an active ingredient fused protein in which a polypeptide having a coiled-coil forming unit is bound to the knob region in the fiber protein of EDS virus (EDSV).
    Type: Application
    Filed: March 16, 2015
    Publication date: February 16, 2017
    Applicants: The Chemo-Sero-Therapeutic Research Institute, Jectas Innovators Company Limited
    Inventors: Kenichi YAMAZAKI, Kiyohiko ANDOH, Ryuichi SAKAMOTO, Kiyotaka SUENAGA, Takeshi ARAKAWA, Hirotaka UEFUJI, Tetsuya HARAKUNI, Takeshi MIYATA
  • Process for preparing inclusion body-forming protein
    Patent number: 8748132
    Abstract: A process for preparing an inclusion body-forming protein is provided. A nucleic acid fragment having a nucleotide sequence coding for a modified alkaline phosphatase signal peptide (modified APSP) where leucine at the 13th position in the amino acid sequence shown in SEQ ID NO: 1 is substituted with proline and/or alanine at the 21st position is substituted with the other amino acid, downstream of which nucleotide sequence is bound a nucleotide sequence of a gene of a protein of interest is also provided.
    Type: Grant
    Filed: October 21, 2009
    Date of Patent: June 10, 2014
    Assignees: The Chemo-Sero-Therapeutic Research Institute, Teijin Pharma Limited
    Inventors: Hiroshi Nakatake, Akihiro Meta, Kiyotaka Suenaga, Masaki Hirashima, Hiroaki Maeda
  • PROCESS FOR PREPARING INCLUSION BODY-FORMING PROTEIN
    Publication number: 20110262998
    Abstract: A process for preparing an inclusion body-forming protein is provided.
    Type: Application
    Filed: October 21, 2009
    Publication date: October 27, 2011
    Applicants: TEIJIN PHARMA LIMITED, THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
    Inventors: Hiroshi Nakatake, Akihiro Meta, Kiyotaka Suenaga, Masaki Hirashima, Hiroaki Maeda